References
- KerscherMRollSBeckerAComparison of the spread of three botulinum toxin type A preparationsArch Dermatol Res201230415516122002325
- TorresSHamiltonMSanchesEStarovatovaPGubanovaEReshetnikovaTNeutralizing antibodies to botulinum neurotoxin type A in aesthetic medicine: five case reportsClin Cosmet Investig Dermatol201371117
- KaneMAGoldMHColemanWP3rdA randomized, double-blind trial to investigate the equivalence of incobotulinumtoxinA and onabotulinumtoxinA for glabellar frown linesDermatol Surg2015411310131926509943
- SattlerGCallanderMGrablowitzDNon-inferiority of NT201, free from complexing proteins, compared with another botulinum toxin type A in the treatment of glabellar frown linesDermatol Surg201036Suppl 42146215421134045
- PragerWWissmüllerEKollhorstBComparison of two botulinum toxin type A preparations for treating crow’s feet: a split-face, double-blind, proof-of-concept studyDermatol Surg2010362155216021134046
- MutiGHarringtonLA prospective rater- and subject-blinded study comparing the efficacy of incobotulinumtoxinA and onabotulinumtoxinA to treat crow’s feet: a clinical crossover evaluationDermatol Surg201541Suppl 1S39S4625548844
- YutskovskayaYGubanovaEKhrustalevaIIncobotulinumtoxinA in aesthetics: Russian multidisciplinary expert consensus recommendationsClin Cosmet Investig Dermatol20158297306
- AscherBTalaricoSCassutoDInternational consensus recommendations on the aesthetic usage of botulinum toxin type A (Speywood Unit) – Part I: upper facial wrinklesJ Eur Acad Dermatol Venereol2010241278128420337830
- KaneMDonofrioLAscherBExpanding the use of neurotoxins in facial aesthetics: a consensus panel’s assessment and recommendationsJ Drugs Dermatol20109s7s2220919448
- RaspaldoHBaspeyrasMBellityPConsensus Group. Upper- and mid-face anti-aging treatment and prevention using onabotulinumtoxin A: the 2010 multidisciplinary French consensus – part 1J Cosmet Dermatol201110365021332914
- RaspaldoHNiforosFRGassiaVConsensus GroupLower-face and neck antiaging treatment and prevention using onabotulinumtoxin A: the 2010 multidisciplinary French consensus – part 2J Cosmet Dermatol20111013114921649819
- AhnBKKimYSKimHJRhoNKKimHSConsensus recommendations on the aesthetic usage of botulinum toxin type A in AsiansDermatol Surg2013391843186024118218
- CarruthersAKaneMAFlynnTCThe convergence of medicine and neurotoxins: a focus on botulinum toxin type A and its application in aesthetic medicine – a global, evidence-based botulinum toxin consensus education initiative: part I: botulinum toxin in clinical and cosmetic practiceDermatol Surg20133949350923458294
- CarruthersJFournierNKerscherMRuiz-AvilaJTrindade de AlmeidaARKaeuperGThe convergence of medicine and neurotoxins: a focus on botulinum toxin type A and its application in aesthetic medicine – a global, evidence-based botulinum toxin consensus education initiative: part II: incorporating botulinum toxin into aesthetic clinical practiceDermatol Surg20133951052523458295
- LorencZPKenkelJMFagienSConsensus panel’s assessment and recommendations on the use of 3 botulinum toxin type A products in facial aestheticsAesthet Surg J201333Suppl 135S40S23515197
- SundaramHSignoriniMLiewSGlobal Aesthetics Consensus GroupGlobal Aesthetics Consensus: botulinum toxin type A – evidence-based review, emerging concepts, and consensus recommendations for aesthetic use, including updates on complicationsPlast Reconstr Surg2016137518e529e
- De MaioMRzanyBPatient selectionDe MaioMRzanyBBotulinum Toxin in Aesthetic MedicineBerlinSpringer20071119
- LorencZPSmithSNestorMNelsonDMoradiAUnderstanding the functional anatomy of the frontalis and glabellar complex for optimal aesthetic botulinum toxin type A therapyAesthetic Plast Surg20133797598323846022
- KerscherMRzanyBPragerWTurnbullCTrevidicPInglefieldCEfficacy and safety of incobotulinumtoxinA in the treatment of upper facial lines: results from a randomized, double-blind, placebo-controlled, phase III studyDermatol Surg2015411149115726359996
- FlynnTCBotox in menDermatol Ther20072040741318093014
- KeaneyTCAlsterTSBotulinum toxin in men: review of relevant anatomy and clinical trial dataDermatol Surg2013391434144324090254
- SpiegelJHGoerigRCLuflerRSHoaglandTMFrontalis midline dehiscence: an anatomical study and discussion of clinical relevanceJ Plast Reconstr Aesthet Surg20096295095418468501
- KaneMABrandtFRohrichRJEvaluation of variable-dose treatment with a new US botulinum toxin type a (Dysport) for correction of moderate to severe glabellar lines: results from a phase III, randomized, double-blind, placebo-controlled studyPlast Reconstr Surg20091241619162919584772
- De AlmeidaARda Costa MarquesERBanegasRKaduncBVGlabellar contraction patterns: a tool to optimize botulinum toxin treatmentDermatol Surg2012381506151522804914
- MonheitGLinXNelsonDKaneMConsideration of muscle mass in glabellar line treatment with botulinum toxin type AJ Drugs Dermatol2012111041104523135645
- XieYZhouJLiHChengCHerrlerTLiQClassification of masseter hypertrophy for tailored botulinum toxin type A treatmentPlast Reconstr Surg2014134209e218e
- GiacomoniPUMammoneTTeriMGender-linked differences in human skinJ Dermatol Sci20095514414919574028